227 related articles for article (PubMed ID: 15846122)
1. Dose-dependent effects of 4-hydroxytamoxifen, the active metabolite of tamoxifen, on estrogen receptor-alpha expression in the rat uterus.
Reed CA; Berndtson AK; Nephew KP
Anticancer Drugs; 2005 Jun; 16(5):559-67. PubMed ID: 15846122
[TBL] [Abstract][Full Text] [Related]
2. Effects of SERM (selective estrogen receptor modulator) treatment on growth and proliferation in the rat uterus.
Stygar D; Muravitskaya N; Eriksson B; Eriksson H; Sahlin L
Reprod Biol Endocrinol; 2003 May; 1():40. PubMed ID: 12777179
[TBL] [Abstract][Full Text] [Related]
3. Effect of genistein as a selective estrogen receptor beta agonist on the expression of Calbindin-D9k in the uterus of immature rats.
Lee GS; Choi KC; Kim HJ; Jeung EB
Toxicol Sci; 2004 Dec; 82(2):451-7. PubMed ID: 15456916
[TBL] [Abstract][Full Text] [Related]
4. Strain differences in tamoxifen sensitivity of Sprague-Dawley and Fischer 344 rats.
Bailey JA; Nephew KP
Anticancer Drugs; 2002 Oct; 13(9):939-47. PubMed ID: 12394257
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of the short-term effects of a novel selective estrogen receptor modulator, ospemifene, and raloxifene and tamoxifen on rat uterus.
Zheng H; Kangas L; Härkönen PL
J Steroid Biochem Mol Biol; 2004 Feb; 88(2):143-56. PubMed ID: 15084346
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen regulation of bone growth and endocrine function in the ovariectomized rat: discrimination of responses involving estrogen receptor α/estrogen receptor β, G protein-coupled estrogen receptor, or estrogen-related receptor γ using fulvestrant (ICI 182780).
Fitts JM; Klein RM; Powers CA
J Pharmacol Exp Ther; 2011 Jul; 338(1):246-54. PubMed ID: 21464335
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor alpha pathway is involved in the regulation of Calbindin-D9k in the uterus of immature rats.
Lee GS; Kim HJ; Jung YW; Choi KC; Jeung EB
Toxicol Sci; 2005 Apr; 84(2):270-7. PubMed ID: 15635152
[TBL] [Abstract][Full Text] [Related]
8. TAS-108, a novel oral steroidal antiestrogenic agent, is a pure antagonist on estrogen receptor alpha and a partial agonist on estrogen receptor beta with low uterotrophic effect.
Yamamoto Y; Shibata J; Yonekura K; Sato K; Hashimoto A; Aoyagi Y; Wierzba K; Yano S; Asao T; Buzdar AU; Terada T
Clin Cancer Res; 2005 Jan; 11(1):315-22. PubMed ID: 15671561
[TBL] [Abstract][Full Text] [Related]
9. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells.
Vivacqua A; Bonofiglio D; Recchia AG; Musti AM; Picard D; Andò S; Maggiolini M
Mol Endocrinol; 2006 Mar; 20(3):631-46. PubMed ID: 16239258
[TBL] [Abstract][Full Text] [Related]
10. Regulation of estrogen target genes and growth by selective estrogen-receptor modulators in endometrial cancer cells.
Dardes RC; Schafer JM; Pearce ST; Osipo C; Chen B; Jordan VC
Gynecol Oncol; 2002 Jun; 85(3):498-506. PubMed ID: 12051881
[TBL] [Abstract][Full Text] [Related]
11. ICI 182,780 inhibits endogenous estrogen-dependent rat uterine growth and tamoxifen-induced developmental toxicity.
Branham WS; Fishman R; Streck RD; Medlock KL; De George JJ; Sheehan DM
Biol Reprod; 1996 Jan; 54(1):160-7. PubMed ID: 8838013
[TBL] [Abstract][Full Text] [Related]
12. Differential spatiotemporal regulation of lactoferrin and progesterone receptor genes in the mouse uterus by primary estrogen, catechol estrogen, and xenoestrogen.
Das SK; Tan J; Johnson DC; Dey SK
Endocrinology; 1998 Jun; 139(6):2905-15. PubMed ID: 9607801
[TBL] [Abstract][Full Text] [Related]
13. The antiestrogen tamoxifen induces c-fos and jun-B, but not c-jun or jun-D, protooncogenes in the rat uterus.
Nephew KP; Polek TC; Akcali KC; Khan SA
Endocrinology; 1993 Jul; 133(1):419-22. PubMed ID: 8319588
[TBL] [Abstract][Full Text] [Related]
14. Contrasting effects of tamoxifen and ICI 182 780 on estrogen-induced calbindin-D 9k gene expression in the uterus and in primary culture of myometrial cells.
Blin C; L'Horset F; Leclerc T; Lambert M; Colnot S; Thomasset M; Perret C
J Steroid Biochem Mol Biol; 1995 Oct; 55(1):1-7. PubMed ID: 7577712
[TBL] [Abstract][Full Text] [Related]
15. Tissue- and hormone-dependent progesterone receptor distribution in the rat uterus.
Sahlin L; Masironi B; Akerberg S; Eriksson H
Reprod Biol Endocrinol; 2006 Sep; 4():47. PubMed ID: 16965620
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen stimulates expression of the c-fos proto-oncogene in rodent uterus.
Kirkland JL; Murthy L; Stancel GM
Mol Pharmacol; 1993 May; 43(5):709-14. PubMed ID: 8502228
[TBL] [Abstract][Full Text] [Related]
17. Modulation of AP-1 mediated estrogenic response by ormeloxifene in rat uterus.
Awasthi S; Daverey A; Dwivedi A
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):208-14. PubMed ID: 17553677
[TBL] [Abstract][Full Text] [Related]
18. Regulation of estrogen receptor (ER) isoform messenger RNA expression by different ER ligands in female rat pituitary.
Tena-Sempere M; Navarro VM; Mayen A; Bellido C; Sánchez-Criado JE
Biol Reprod; 2004 Mar; 70(3):671-8. PubMed ID: 14613904
[TBL] [Abstract][Full Text] [Related]
19. Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells.
Kallio A; Guo T; Lamminen E; Seppänen J; Kangas L; Väänänen HK; Härkönen P
Mol Cell Endocrinol; 2008 Jul; 289(1-2):38-48. PubMed ID: 18455292
[TBL] [Abstract][Full Text] [Related]
20. Antagonism to estradiol in the mouse: reduced entry of receptors complexed with 4-hydroxytamoxifen into a Mg2+-soluble chromatin fraction.
Pavlik EJ; van Nagell JR; Nelson K; Gallion H; Donaldson ES; Kenady DE; Baranowska-Kortylewicz J
Endocrinology; 1986 May; 118(5):1924-34. PubMed ID: 2422013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
